Abstract
Schizophrenic patients with the apolipoprotein E (APOE = gene; apoE = protein) ε4 allele exhibited lower psychosis scores than patients without the ε4 allele in previous reports. The present study tested the hypothesis that the APOE ε4 allele confers association with the clinical manifestations of schizophrenia or clozapine response. A total of 95 schizophrenic patients who were treatment resistant were included in the study. The results demonstrated that the presence of the APOE ε4 allele did not influence the response to clozapine in schizophrenic patients, neither was the baseline psychopathology related to the APOE ε4 allele. Given the multiple functions of the apoE protein in the brain, further study of the influence of APOE on CNS medication response is needed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
